Hb E-beta thalassemia is a major public health problem in West Bengal, India and is the predominant symptom producing thalassemia in this part of the country. To search for an easy, reliable and cost effective screening method for HbE that can be used at the community level where more sophisticated methods are not readily available. And the DCIP test was performed for the purpose. Blood samples of 425 asymptomatic family members from 80 diagnosed cases of HbE beta Thalassemia patients were tested for Hb, RBC indices, DCIP test, HPLC, and in discordant cases confirmed by DNA mutation analysis. The present study shows DCIP screening test to have a sensitivity, specificity, positive predictive value and negative predictive value of 96.39%, 97.43%, 96.39% and 97.43% respectively. It also shows a false positive rate and false negative rate in 2.56% and 4.6% cases respectively. The advantage with DCIP over HPLC is that it can be easily performed at the community level by a person with minimum technical skill, few samples (even a single sample) can be tested at time, at a low cost.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Bain BJ (2006) Other significant hemoglobinopathies. In: Hemoglobinopathy diagnosis, vol 2/e, Blackwell Publishing, pp 191–213
Bain BJ, Wild BJ, Stephens AD, Phelan LA (2010) Common hemoglobins of major clinical importance. In: Variant hemoglobin’s: a guide to identification, vol 1/e, Wiley-Blackwell, Oxford, pp 41–45
Kulapongs P, Sanguansermsri T, Mertz G, Tawarat S (1976) Dichlorophenolindophenol (DCIP) precipitation test: a new screening test for Hb E and H. Pediatr Soc Thail 15:1–7
Fucharoen G, Sanchaisuriya K, Sae-ung N, Dangwibul S, Fucharoen S (2004) A simplified screening strategy for thalassaemia and haemoglobin E in rural communities in Southeast Asia. Bull World Health Organ 82:364–372
Carrel RW, Kay R (1972) A simple method for the detection of unstable hemoglobins. Br J Hematol 23:615–619. https://doi.org/10.1111/j.1365-2141.1972.tb07096.x
Elles R, Old JM (1987) Laboratory procedures for DNA analysis. In: WHO training course in standard techniques and advances methodologies for the control of hereditary anemias. WHO, Herakleon, Greece, p 5
Newton CR, Graham A, Hiptinstall LE et al (1989) Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucl Acid Res 17:2503–2516
Chernoff AL, Minnich V, Chongchareonsuk S (1954) Hemoglobin E, a hereditary abnormality of human hemoglobin. Science 120:605–606
Itano HA, Bergren WR, Sturgeon P (1954) Identification of a fourth abnormal hemoglobin. J Am Chem Soc 76:2278
Chatterjea JB, Saha AK, Ray RN et al (1956) Electrophoretic analysis of haemoglobin in Cooley’s anaemia (thalassemia). Evidences of interaction of thalassemia gene with abnormal hemoglobin. Bull Calcutta Sch Trop Med 4:103–105
National task force study on Thalassemia-2005 (2008) Jai Vigyan S&T Mission project on community control of thalassemia syndromes: awareness, screening, genetic counseling and prevention, Indian Council of Medical Research (ICMR), New Delhi, p 21
Sanchaisuriya K, Fucharoen S, Fucharoen G, Ratanasiri T, Sanchaisuriya P, Changtrakul Y et al (2005) A reliable screening protocol for thalassemia and hemoglobinopathies in pregnancy; an alternative approach to electronic blood cell counting. Am J Clin Pathol 123:113–118
Chandrashekar V, Soni M (2011) Hemoglobin disorders in South India. ISRN Hematol 2011:1–6
Vichinsky E (2007) Hemoglobin e syndromes. Hematol Am Soc Hematol Educ Progr 2007:79–83
Sanchaisuriya K, Fucharoen G, Sae-ung N, Sae-un N, Baisungneon R, Jetsrisuparb A, Fucharoen S (1997) Molecular and hematological characterization of HbE heterozygotes with alpha-thalassemia determinant. Southeast Asian J Trop Med Public Health 28:100–103
Balgir RS (1996) Genetic epidemiology of the three predominant abnormal hemoglobins in India. J Assoc Phys India 25:44–48
Tyagi S, Saxena R, Choudhry VP (2003) HPLC: how necessary is it for haemoglobinopathy diagnosis in India? Indian J Pathol Microbiol 46:390–393
Chapple L, Harris A, Phelan L, Bain BJ (2006) Reassessment of a simple chemical method using DCIP for screening for haemoglobin E. J Clin Pathol 59:74–76
Prayongratana K, Polprasert C, Raungrongmorakot K, Tatone K, Santiwatanakul S (2008) Low cost combination of DCIP and MCV was better than that of DCIP and OF in the screening for hemoglobin E. J Med Assoc Thail 91:1499–1504
Jaiwang P, Meemungthum I, Wiwanitkit V (2007) Positive DCIP rates: a study on its incidence in laboratory. Chula Med J 51:101–104
Wilson JMG, Jungner G (1968) Principles and practice for screening for disease, WHO, Geneva, Pub Hlth Paper No. 34
Cochrane AL, Holland WW (1971) Validation of screening procedures. Br Med Bull 27:3–8
Conflict of interest
The authors declare no potential conflicts of interest.
The study was approved by the Institutional Ethical Committee (IEC).
Written consent taken from each patient and/or their legal guardians at the entry into the study.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Mandal, P.K., Nataraj, K.S., Baul, S.N. et al. Efficacy of Dichlorophenolindophenol (DCIP) as Screening Test for Hb E: Revisited. Indian J Hematol Blood Transfus 36, 535–541 (2020). https://doi.org/10.1007/s12288-019-01235-1
- Hemoglobin E
- Screening test